Cargando…

The Expression of VEGF-A Is Down Regulated in Peripheral Blood Mononuclear Cells of Patients with Secondary Progressive Multiple Sclerosis

BACKGROUND: Most patients with relapsing-remitting multiple sclerosis (RRMS) eventually enter a secondary progressive (SPMS) phase, characterized by increasing neurological disability. The mechanisms underlying transition to SPMS are unknown and effective treatments and biomarkers are lacking. Vascu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iacobaeus, Ellen, Amoudruz, Petra, Ström, Mikael, Khademi, Mohsen, Brundin, Lou, Hillert, Jan, Kockum, Ingrid, Malmström, Vivianne, Olsson, Tomas, Tham, Emma, Piehl, Fredrik
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089609/ https://www.ncbi.nlm.nih.gov/pubmed/21573104 http://dx.doi.org/10.1371/journal.pone.0019138

Ejemplares similares

Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis
por: Bergman, Petra, et al.
Publicado: (2016)

Assessing the Preanalytical Variability of Plasma and Cerebrospinal Fluid Processing and Its Effects on Inflammation-Related Protein Biomarkers
por: Huang, Jesse, et al.
Publicado: (2021)

Confounding effect of blood volume and body mass index on blood neurofilament light chain levels
por: Manouchehrinia, Ali, et al.
Publicado: (2020)

The Temporal Retinal Nerve Fiber Layer Thickness Is the Most Important Optical Coherence Tomography Estimate in Multiple Sclerosis
por: Birkeldh, Ulrika, et al.
Publicado: (2017)

IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment
por: Zickert, Agneta, et al.
Publicado: (2015)

Spasticity treatment patterns among people with multiple sclerosis: a Swedish cohort study
por: Smith, Kelsi A, et al.
Publicado: (2023)

Inflammation-related plasma and CSF biomarkers for multiple sclerosis
por: Huang, Jesse, et al.
Publicado: (2020)

Intense Inflammation and Nerve Damage in Early Multiple Sclerosis Subsides at Older Age: A Reflection by Cerebrospinal Fluid Biomarkers
por: Khademi, Mohsen, et al.
Publicado: (2013)

Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis
por: Manouchehrinia, Ali, et al.
Publicado: (2020)

The DQB1(*)03:02 Genotype and Treatment for Pain in People With and Without Multiple Sclerosis
por: Burkill, Sarah, et al.
Publicado: (2020)

The national incidence of PML in Sweden, 1988–2013
por: Iacobaeus, Ellen, et al.
Publicado: (2018)

B cell alterations during BAFF inhibition with belimumab in SLE
por: Ramsköld, Daniel, et al.
Publicado: (2018)

Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis
por: Åkesson, Julia, et al.
Publicado: (2023)

Small noncoding RNA profiling across cellular and biofluid compartments and their implications for multiple sclerosis immunopathology
por: Zheleznyakova, Galina Yurevna, et al.
Publicado: (2021)

Low fish consumption is associated with a small increased risk of MS
por: Hedström, Anna Karin, et al.
Publicado: (2020)

Low sun exposure increases multiple sclerosis risk both directly and indirectly
por: Hedström, Anna Karin, et al.
Publicado: (2019)

Non-parametric combination analysis of multiple data types enables detection of novel regulatory mechanisms in T cells of multiple sclerosis patients
por: Fernandes, Sunjay Jude, et al.
Publicado: (2019)

Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
por: Christensen, Jeppe Romme, et al.
Publicado: (2013)

Correction: Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
por: Romme Christensen, Jeppe, et al.
Publicado: (2013)

Association between brain volume and disability over time in multiple sclerosis
por: Moridi, Thomas, et al.
Publicado: (2022)

Aggressive multiple sclerosis (1): Towards a definition of the phenotype
por: Iacobaeus, Ellen, et al.
Publicado: (2020)

Aggressive multiple sclerosis (2): Treatment
por: Arrambide, Georgina, et al.
Publicado: (2020)

Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS
por: Duell, Frida, et al.
Publicado: (2020)

Smoking Attributable Risk in Multiple Sclerosis
por: Manouchehrinia, Ali, et al.
Publicado: (2022)

Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis—A Phase I Study
por: Iacobaeus, Ellen, et al.
Publicado: (2019)

Stressful life events are associated with the risk of multiple sclerosis
por: Jiang, X., et al.
Publicado: (2020)

The familial risk and heritability of multiple sclerosis and its onset phenotypes: A case–control study
por: Boles, Graysen Steele, et al.
Publicado: (2023)

B‐cell repopulation dynamics and drug pharmacokinetics impact SARS‐CoV‐2 vaccine efficacy in anti‐CD20‐treated multiple sclerosis patients
por: Asplund Högelin, Klara, et al.
Publicado: (2022)

Fine Mapping of Gene Regions Regulating Neurodegeneration
por: Swanberg, Maria, et al.
Publicado: (2009)

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
por: Novakova, Lenka, et al.
Publicado: (2017)

Sustained Low Relapse Rate With Highly Variable B-Cell Repopulation Dynamics With Extended Rituximab Dosing Intervals in Multiple Sclerosis
por: Starvaggi Cucuzza, Chiara, et al.
Publicado: (2022)

Association between exposure to combustion-related air pollution and multiple sclerosis risk
por: Hedström, Anna Karin, et al.
Publicado: (2023)

JC Polyomavirus Infection Is Strongly Controlled by Human Leucocyte Antigen Class II Variants
por: Sundqvist, Emilie, et al.
Publicado: (2014)

Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies
por: Grundtman, Cecilia, et al.
Publicado: (2007)

Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis
por: Asplund Högelin, Klara, et al.
Publicado: (2021)

Gene Expression of VEGF-A and VEGF-C in Peripheral Blood Mononuclear Cells of Iranian Patients with Acute Myeloid Leukemia
por: Aliparasti, Mohammad Reza, et al.
Publicado: (2013)

Cell Fusion along the Anterior-Posterior Neuroaxis in Mice with Experimental Autoimmune Encephalomyelitis
por: Sankavaram, Sreenivasa R., et al.
Publicado: (2015)

Complement Component C3 and Butyrylcholinesterase Activity Are Associated with Neurodegeneration and Clinical Disability in Multiple Sclerosis
por: Aeinehband, Shahin, et al.
Publicado: (2015)

Cerebrospinal fluid levels of neuroinflammatory biomarkers are increased in athletes with persistent post-concussive symptoms following sports-related concussion
por: Gard, Anna, et al.
Publicado: (2023)

Smoking and Epstein–Barr virus infection in multiple sclerosis development
por: Hedström, Anna Karin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ibgrramk7f2h8ti4f3kfgnej0m